Cetuximab

Red

Brand Name(s):Erbitux

Indication:Colorectal cancer (metastatic) only (First-line treatment

Rationale:1,2,3,8

Considered:Apr-09

Review Date:Mar-24

Comments:
MHRA Drug Safety Update
Importance of establishing wild type RAS (KRAS and NRAS) status before treatment of metastatic colorectal cancer; http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON377644

February 2014